Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Alcentra Capital

Nasdaq:ABDC
Snowflake Description

High growth potential and good value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
ABDC
Nasdaq
$115M
Market Cap
  1. Home
  2. US
  3. Diversified Financials
Company description

Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The last earnings update was 90 days ago. More info.


Add to Portfolio Compare Print
  • Alcentra Capital is a fund or ETF! Currently our data availability for these is poor, we only recommend using them as part of a portfolio.
ABDC Share Price and Events
7 Day Returns
-4.1%
NasdaqGS:ABDC
-0.1%
US Capital Markets
-1.5%
US Market
1 Year Returns
16.2%
NasdaqGS:ABDC
16.2%
US Capital Markets
17.2%
US Market
ABDC Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Alcentra Capital (ABDC) -4.1% -2.5% 0.6% 16.2% -27.5% -34.1%
US Capital Markets -0.1% 1.5% 7.6% 16.2% 32.5% 65.9%
US Market -1.5% -0.5% 5% 17.2% 36.8% 50.6%
1 Year Return vs Industry and Market
  • ABDC matched the Capital Markets industry (16.2%) over the past year.
  • ABDC underperformed the Market in United States of America which returned 17.2% over the past year.

Value

 Is Alcentra Capital undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Alcentra Capital. This is due to cash flow or dividend data being unavailable. The share price is $8.9.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Alcentra Capital's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Alcentra Capital's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqGS:ABDC PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in USD $0.54
NasdaqGS:ABDC Share Price ** NasdaqGS (2020-01-31) in USD $8.9
United States of America Capital Markets Industry PE Ratio Median Figure of 82 Publicly-Listed Capital Markets Companies 37.46x
United States of America Market PE Ratio Median Figure of 2,906 Publicly-Listed Companies 18.09x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Alcentra Capital.

NasdaqGS:ABDC PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqGS:ABDC Share Price ÷ EPS (both in USD)

= 8.9 ÷ 0.54

16.55x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Alcentra Capital is good value based on earnings compared to the US Capital Markets industry average.
  • Alcentra Capital is good value based on earnings compared to the United States of America market.
Price based on expected Growth
Does Alcentra Capital's expected growth come at a high price?
Raw Data
NasdaqGS:ABDC PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 16.55x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts
93.1%per year
United States of America Capital Markets Industry PEG Ratio Median Figure of 39 Publicly-Listed Capital Markets Companies 2.65x
United States of America Market PEG Ratio Median Figure of 2,017 Publicly-Listed Companies 1.49x

*Line of best fit is calculated by linear regression .

NasdaqGS:ABDC PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 16.55x ÷ 93.1%

0.18x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Alcentra Capital is good value based on expected growth next year.
Price based on value of assets
What value do investors place on Alcentra Capital's assets?
Raw Data
NasdaqGS:ABDC PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in USD $10.98
NasdaqGS:ABDC Share Price * NasdaqGS (2020-01-31) in USD $8.9
United States of America Capital Markets Industry PB Ratio Median Figure of 151 Publicly-Listed Capital Markets Companies 6.64x
United States of America Market PB Ratio Median Figure of 5,100 Publicly-Listed Companies 1.79x
NasdaqGS:ABDC PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqGS:ABDC Share Price ÷ Book Value per Share (both in USD)

= 8.9 ÷ 10.98

0.81x

* Primary Listing of Alcentra Capital.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Alcentra Capital is good value based on assets compared to the US Capital Markets industry average.
X
Value checks
We assess Alcentra Capital's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Capital Markets industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Capital Markets industry average (and greater than 0)? (1 check)
  5. Alcentra Capital has a total score of 4/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Alcentra Capital expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
93.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Alcentra Capital expected to grow at an attractive rate?
  • Alcentra Capital's earnings growth is expected to exceed the low risk savings rate of 1.7%.
Growth vs Market Checks
  • Alcentra Capital's earnings growth is expected to exceed the United States of America market average.
  • Alcentra Capital's revenue growth is expected to exceed the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NasdaqGS:ABDC Future Growth Rates Data Sources
Data Point Source Value (per year)
NasdaqGS:ABDC Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts 93.1%
NasdaqGS:ABDC Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 2 Analysts 52.9%
United States of America Capital Markets Industry Earnings Growth Rate Market Cap Weighted Average 8.5%
United States of America Capital Markets Industry Revenue Growth Rate Market Cap Weighted Average 5.1%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14.5%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.6%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqGS:ABDC Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqGS:ABDC Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 82 45 1
2020-12-31 23 6 2
2020-02-04
2019-12-31 24 19 7 3
NasdaqGS:ABDC Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-09-30 25 39 7
2019-06-30 26 43 8
2019-03-31 27 37 4
2018-12-31 29 78 6
2018-09-30 30 28 -9
2018-06-30 31 6 -14
2018-03-31 32 10 -17
2017-12-31 33 -31 -19
2017-09-30 36 19 -1
2017-06-30 38 21 -1
2017-03-31 40 7 6
2016-12-31 41 28 9

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Alcentra Capital's earnings are expected to grow significantly at over 20% yearly.
  • Alcentra Capital's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqGS:ABDC Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below

All data from Alcentra Capital Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGS:ABDC Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31 0.73 0.73 0.73 1.00
2020-12-31 0.44 0.44 0.44 1.00
2020-02-04
2019-12-31 0.59 0.59 0.59 1.00
NasdaqGS:ABDC Past Financials Data
Date (Data in USD Millions) EPS *
2019-09-30 0.54
2019-06-30 0.63
2019-03-31 0.29
2018-12-31 0.40
2018-09-30 -0.65
2018-06-30 -0.98
2018-03-31 -1.18
2017-12-31 -1.37
2017-09-30 -0.06
2017-06-30 -0.08
2017-03-31 0.41
2016-12-31 0.65

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Alcentra Capital is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Alcentra Capital's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Alcentra Capital has a total score of 5/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Alcentra Capital performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Alcentra Capital's growth in the last year to its industry (Capital Markets).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Alcentra Capital's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.
  • Alcentra Capital has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
  • Alcentra Capital has become profitable in the last year making it difficult to compare the US Capital Markets industry average.
Earnings and Revenue History
Alcentra Capital's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Alcentra Capital Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqGS:ABDC Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 25.15 7.00 7.52
2019-06-30 26.10 8.33 6.87
2019-03-31 27.21 3.95 6.59
2018-12-31 28.97 5.52 7.42
2018-09-30 30.19 -8.99 7.60
2018-06-30 31.25 -13.68 6.84
2018-03-31 32.33 -16.59 6.66
2017-12-31 33.35 -19.10 7.21
2017-09-30 36.05 -0.81 8.00
2017-06-30 37.56 -1.04 9.58
2017-03-31 39.86 5.51 11.12
2016-12-31 40.60 8.79 11.19
2016-09-30 38.38 1.82 10.97
2016-06-30 37.77 6.92 10.45
2016-03-31 35.64 11.93 9.92
2015-12-31 33.92 12.61 9.61
2015-09-30 39.99 25.07 10.17
2014-12-31 24.25 22.10 4.83

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Alcentra Capital has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Alcentra Capital used its assets more efficiently than the US Capital Markets industry average last year based on Return on Assets.
  • Alcentra Capital's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Alcentra Capital's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Capital Markets industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Alcentra Capital has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Alcentra Capital's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Alcentra Capital's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Alcentra Capital is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Alcentra Capital's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Alcentra Capital's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Alcentra Capital Company Filings, last reported 4 months ago.

NasdaqGS:ABDC Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 141.37 83.11 4.83
2019-06-30 141.94 80.92 7.80
2019-03-31 143.86 82.82 4.36
2018-12-31 145.80 82.68 11.05
2018-09-30 149.81 108.51 7.79
2018-06-30 149.59 112.52 12.70
2018-03-31 157.18 109.28 13.42
2017-12-31 157.71 143.45 13.88
2017-09-30 174.82 113.45 4.93
2017-06-30 181.28 88.70 3.80
2017-03-31 180.42 100.53 4.72
2016-12-31 184.52 92.64 3.89
2016-09-30 184.66 124.32 6.71
2016-06-30 191.09 101.82 5.04
2016-03-31 194.57 86.83 3.83
2015-12-31 195.03 102.35 4.87
2015-09-30 201.73 92.65 11.47
2014-12-31 200.99 62.50 10.02
  • Alcentra Capital's level of debt (58.8%) compared to net worth is high (greater than 40%).
  • Unable to establish if Alcentra Capital's debt level has increased without past 5-year debt data.
  • Debt is well covered by operating cash flow (46.5%, greater than 20% of total debt).
  • Interest payments on debt are not well covered by earnings (EBIT is 2.5x annual interest expense, ideally 3x coverage).
X
Financial health checks
We assess Alcentra Capital's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Alcentra Capital has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Alcentra Capital's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
8.09%
Current annual income from Alcentra Capital dividends. Estimated to be 9.74% next year.
If you bought $2,000 of Alcentra Capital shares you are expected to receive $162 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Alcentra Capital's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.45%).
  • Alcentra Capital's dividend is above the markets top 25% of dividend payers in United States of America (3.76%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqGS:ABDC Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
United States of America Capital Markets Industry Average Dividend Yield Market Cap Weighted Average of 43 Stocks 1.9%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1964 Stocks 2.3%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.5%
United States of America Top 25% Dividend Yield 75th Percentile 3.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NasdaqGS:ABDC Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2021-12-31 1.16 2.00
2020-12-31 0.72 4.00
2020-02-04
2019-12-31 0.80 4.00
NasdaqGS:ABDC Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-10-14 0.720 7.938
2019-08-07 0.720 8.152
2019-05-06 0.720 8.617
2019-03-12 0.720 9.180
2018-11-06 0.720 10.569
2018-11-05 0.720 11.805
2018-08-07 0.720 11.834
2018-08-06 0.720 11.577
2018-03-14 0.720 10.959
2017-11-07 1.000 12.520
2017-08-04 1.360 13.076
2017-08-03 1.360 11.788
2017-05-05 1.360 10.320
2017-05-04 1.360 9.643
2017-03-10 1.360 9.793
2017-03-09 1.360 10.631
2016-11-04 1.360 11.090
2016-11-03 1.360 10.609
2016-08-05 1.360 10.678
2016-08-04 1.360 11.080
2016-05-06 1.360 11.236
2016-05-05 1.360 11.631
2016-03-09 1.360 11.930
2015-12-21 1.360 13.106
2015-11-10 1.360 11.459
2015-08-11 1.360 11.007
2015-03-17 1.360 10.155
2014-08-21 1.360 10.413
2014-06-25 0.712 5.207

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Alcentra Capital has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).
  • Dividend payments have increased, but Alcentra Capital only paid a dividend in the past 6 years.
Current Payout to shareholders
What portion of Alcentra Capital's earnings are paid to the shareholders as a dividend.
  • Dividends paid are not well covered by earnings (0.7x coverage).
Future Payout to shareholders
  • Dividends after 3 years are not well covered by earnings (0.7x coverage).
X
Income/ dividend checks
We assess Alcentra Capital's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Alcentra Capital afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Alcentra Capital has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Alcentra Capital's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Suhail Shaikh
AGE 50
TENURE AS CEO 0.9 years
CEO Bio

Mr. Suhail A. Shaikh serves as Director of Alcentra Capital Corporation since November 30, 2019. Mr. Shaikh has been Managing Director and Head of US Direct Lending of Alcentra NY LLC, Co-Head of U.S. Direct Lending at Alcentra Ltd. since June 2018. He serves as Chief Executive Officer of Alcentra Capital Corporation and served as its Head of U.S. Direct Lending. Mr. Shaikh served as Managing Director of Alcentra Capital Corp. since May 2018 until March 12, 2019 and served as its Co-President since June 2018 until March 12, 2019. He was Co-Head of US Direct Lending at Alcentra Capital Corp. until 2018. Mr. Shaikh leads Alcentra’s Direct Lending business in the U.S., providing a range of private credit solutions to support middle market sponsors and corporations. He served as Partner at Solar Capital Partners, LLC. Since joining Solar in 2011, Mr. Shaikh was responsible for the origination, structuring and investment of middle market principal credits, spanning 1st lien, 2nd lien and unit ranche transactions. Prior to Solar, he was in investment banking for over 15 years as a leveraged finance specialist and financial sponsor banker, most recently as a Managing Director at Bank of America Merrill Lynch. He previously worked at JPMorgan, CIBC and Bankers Trust. Mr. Shaikh has an M.B.A. from the Wharton School of Business and an A.B. from Middlebury College.

CEO Compensation
  • Insufficient data for Suhail to compare compensation growth.
  • Insufficient data for Suhail to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Alcentra Capital management team in years:

2.8
Average Tenure
50.5
Average Age
  • The tenure for the Alcentra Capital management team is about average.
Management Team

Suhail Shaikh

TITLE
CEO & Director
AGE
50
TENURE
0.9 yrs

Peter Glaser

TITLE
President
TENURE
0.9 yrs

Ellida McMillan

TITLE
CFO, COO
AGE
51
TENURE
2.8 yrs

Steven Levinson

TITLE
Chief Compliance Officer
AGE
52
TENURE
5.9 yrs

Scott Gold

TITLE
Senior Vice President
AGE
46
TENURE
5.9 yrs

Branko Krmpotic

TITLE
Executive Vice President
TENURE
2.8 yrs

Steve Crino

TITLE
Managing Director of Direct Lending
TENURE
2.1 yrs

Prumiys Dulger

TITLE
Deputy US Chief Compliance Officer
TENURE
5.6 yrs
Board of Directors Tenure

Average tenure and age of the Alcentra Capital board of directors in years:

1.4
Average Tenure
59
Average Age
  • The average tenure for the Alcentra Capital board of directors is less than 3 years, this suggests a new board.
Board of Directors

Ed Grebow

TITLE
Independent Chairman of the Board
COMPENSATION
$80K
AGE
69
TENURE
0.3 yrs

Suhail Shaikh

TITLE
CEO & Director
AGE
50
TENURE
0.3 yrs

Douglas Greenlaw

TITLE
Lead Independent Director
COMPENSATION
$75K
AGE
74
TENURE
6.1 yrs

William Wright

TITLE
Independent Director
AGE
59
TENURE
1.4 yrs

Frederick Van Zijl

TITLE
Independent Director
AGE
57
TENURE
1.4 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Alcentra Capital individual insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
23. Dec 19 Buy Suhail Shaikh Individual 23. Dec 19 23. Dec 19 3,000 $9.16 $27,477
19. Dec 19 Buy Edward Grebow Individual 18. Dec 19 18. Dec 19 6,300 $9.14 $57,607
17. Dec 19 Buy Edward Grebow Individual 16. Dec 19 16. Dec 19 5,000 $9.14 $45,720
X
Management checks
We assess Alcentra Capital's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Alcentra Capital has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and oil and gas services sector. It focuses on investment opportunities headquartered in the United States. The fund seeks to invest $5 million to $15 million per transaction in companies with EBITDA between $5 million to $15 million and revenues of between $10 million and $100 million. It invests in the form of subordinated debt and, to a lesser extent, senior debt and minority equity investments.

Details
Name: Alcentra Capital Corporation
ABDC
Exchange: NasdaqGS
Founded: 2013
$114,592,537
12,875,566
Website: http://www.alcentracapital.com
Address: Alcentra Capital Corporation
200 Park Avenue,
Seventh Floor,
New York,
New York, 10166,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqGS ABDC Common Stock Nasdaq Global Select US USD 09. May 2014
Number of employees
Current staff
Staff numbers
0
Alcentra Capital employees.
Industry
Asset Management and Custody Banks
Diversified Financials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/02/04 00:47
End of day share price update: 2020/01/31 00:00
Last estimates confirmation: 2020/01/21
Last earnings filing: 2019/11/06
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.